v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Total Stockholders' Equity
Common Stock
Additional Paid-In Capital
Distributions in Excess of Cumulative Earnings
Accumulated Other Comprehensive Income (Loss)
Non- Controlling Interests
Balance at beginning of period (in shares) at Dec. 31, 2022     142,379,655        
Balance at beginning of period at Dec. 31, 2022 $ 2,496,771 $ 2,488,261 $ 1,424 $ 2,563,305 $ (117,187) $ 40,719 $ 8,510
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuance (in shares)     21,971,744        
Common stock issuance 507,380 507,380 $ 219 507,161      
Common stock withheld related to net share settlement of equity awards (3,671) (3,671)     (3,671)    
Costs related to issuance of common stock (1,010) (1,010)   (1,010)      
Other comprehensive income (loss) (36,874) (36,700)       (36,700) (174)
Equity based compensation expense (in shares)     283,751        
Equity-based compensation expense 9,006 9,006 $ 3 9,003      
Dividends and distributions declared (176,015) (175,394)     (175,394)   (621)
Net income 191,415 190,707     190,707   708
Balance at end of period (in shares) at Dec. 31, 2023     164,635,150        
Balance at end of period at Dec. 31, 2023 2,987,002 2,978,579 $ 1,646 3,078,459 (105,545) 4,019 8,423
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuance (in shares)     22,713,852        
Common stock issuance 570,243 570,243 $ 227 570,016      
Common stock withheld related to net share settlement of equity awards (3,313) (3,313)     (3,313)    
Costs related to issuance of common stock (1,083) (1,083)   (1,083)      
Other comprehensive income (loss) 12,900 12,867       12,867 33
Equity based compensation expense (in shares)     188,590        
Equity-based compensation expense 10,829 10,829 $ 2 10,827      
Dividends and distributions declared (208,089) (207,448)     (207,448)   (641)
Net income $ 203,638 203,004     203,004   634
Balance at end of period (in shares) at Dec. 31, 2024 187,537,592   187,537,592        
Balance at end of period at Dec. 31, 2024 $ 3,572,127 3,563,678 $ 1,875 3,658,219 (113,302) 16,886 8,449
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuance (in shares)     21,893,991        
Common stock issuance 657,589 657,589 $ 219 657,370      
Common stock withheld related to net share settlement of equity awards (6,407) (6,407)     (6,407)    
Costs related to issuance of common stock (633) (633)   (633)      
Other comprehensive income (loss) (37,977) (37,865)       (37,865) (112)
Equity based compensation expense (in shares)     270,850        
Equity-based compensation expense 13,184 13,184 $ 3 13,181      
Dividends and distributions declared (243,720) (242,565)     (242,565)   (1,155)
Net income $ 253,731 253,013     253,013   718
Balance at end of period (in shares) at Dec. 31, 2025 209,702,433   209,702,433        
Balance at end of period at Dec. 31, 2025 $ 4,207,894 $ 4,199,994 $ 2,097 $ 4,328,137 $ (109,261) $ (20,979) $ 7,900